RFG Advisory LLC Takes $261,000 Position in Agilent Technologies, Inc. (NYSE:A)

RFG Advisory LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 1,793 shares of the medical research company’s stock, valued at approximately $261,000.

A number of other institutional investors have also bought and sold shares of A. Park Avenue Securities LLC lifted its holdings in shares of Agilent Technologies by 14.7% in the first quarter. Park Avenue Securities LLC now owns 11,985 shares of the medical research company’s stock worth $1,744,000 after buying an additional 1,532 shares in the last quarter. Czech National Bank boosted its holdings in shares of Agilent Technologies by 0.6% during the 1st quarter. Czech National Bank now owns 51,560 shares of the medical research company’s stock valued at $7,502,000 after purchasing an additional 315 shares during the last quarter. Fulton Bank N.A. grew its position in shares of Agilent Technologies by 6.7% during the first quarter. Fulton Bank N.A. now owns 9,759 shares of the medical research company’s stock valued at $1,420,000 after purchasing an additional 610 shares in the last quarter. Rise Advisors LLC increased its holdings in shares of Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after purchasing an additional 190 shares during the last quarter. Finally, Ferguson Wellman Capital Management Inc. lifted its position in shares of Agilent Technologies by 1.4% in the first quarter. Ferguson Wellman Capital Management Inc. now owns 11,221 shares of the medical research company’s stock worth $1,633,000 after buying an additional 152 shares in the last quarter.

Insider Transactions at Agilent Technologies

In related news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the transaction, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at $6,595,494.08. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, SVP Dominique Grau sold 15,000 shares of the company’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the sale, the senior vice president now directly owns 49,486 shares in the company, valued at approximately $6,595,494.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the transaction, the chief executive officer now owns 25,185 shares in the company, valued at approximately $3,274,050. The disclosure for this sale can be found here.

Agilent Technologies Trading Down 0.3 %

Shares of A opened at $134.72 on Wednesday. The firm has a market capitalization of $39.31 billion, a price-to-earnings ratio of 31.85, a PEG ratio of 4.52 and a beta of 1.07. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35. The company has a 50-day moving average of $139.69 and a 200 day moving average of $138.49.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.03. The firm had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The company’s revenue was down 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.27 earnings per share. On average, research analysts expect that Agilent Technologies, Inc. will post 5.25 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be issued a $0.236 dividend. The ex-dividend date is Tuesday, July 2nd. This represents a $0.94 annualized dividend and a dividend yield of 0.70%. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Stifel Nicolaus reduced their price objective on Agilent Technologies from $163.00 to $151.00 and set a “buy” rating on the stock in a research note on Thursday, May 30th. Robert W. Baird decreased their price target on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a research note on Thursday, May 30th. Citigroup dropped their price objective on shares of Agilent Technologies from $145.00 to $135.00 and set a “neutral” rating for the company in a research note on Thursday, May 30th. TD Cowen decreased their target price on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating on the stock in a research report on Thursday, May 30th. Finally, Oppenheimer lifted their target price on Agilent Technologies from $67.00 to $90.00 and gave the stock an “outperform” rating in a report on Tuesday, March 26th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $136.88.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.